Quince Therapeutics, Inc. - 8-K Filing

The filing appears to be an informational document from the U.S. Securities and Exchange Commission (SEC) outlining its mission, services, and recent activities, including rulemaking efforts, public appointments, and upcoming events.

SEC EDGAR ·

Tickers: $QNCX

Read the full article at SEC EDGAR

More Regulatory news